TY - JOUR
T1 - Psychiatric disorders in young adults diagnosed with juvenile fibromyalgia in adolescence
AU - Cunningham, Natoshia Raishevich
AU - Tran, Susan T.
AU - Lynch-Jordan, Anne M.
AU - Ting, Tracy V.
AU - Sil, Soumitri
AU - Strotman, Daniel
AU - Noll, Jennie G.
AU - Powers, Scott W.
AU - Arnold, Lesley M.
AU - Kashikar-Zuck, Susmita
N1 - Publisher Copyright:
© Copyright 2015 The Journal of Rheumatology. All rights reserved.
PY - 2015/12
Y1 - 2015/12
N2 - Objective. Adolescents with juvenile-onset fibromyalgia (JFM) have increased rates of psychiatric disorders, but to our knowledge no studies have examined psychiatric disorders in adolescents with JFM when they enter young adulthood. This study examined the prevalence of psychiatric disorders in young adults diagnosed with JFM during adolescence and the relationship between mental health diagnoses and physical functioning. Methods. Ninety-one young adults (mean age 21.60, SD 1.96) with a history of JFM being followed as part of a prospective longitudinal study and 30 matched healthy controls (mean age 21.57, SD 1.55) completed a structured interview of psychiatric diagnoses and a self-report measure of physical impairment. Results. Young adults with a history of JFM were more likely to have current and lifetime histories of anxiety disorders (70.3% and 76.9%, respectively) compared with controls (33.3% for both, both p < 0.001). Individuals with JFM were also more likely to have current and lifetime histories of major mood disorders (29.7% and 76.9%, respectively) compared with controls (10% and 40%, p < 0.05). The presence of a current major mood disorder was significantly related to impairment in physical functioning [F (1, 89) = 8.30, p < 0.01] and role limitations attributable to a physical condition [F (1, 89) = 7.09, p < 0.01]. Conclusion. Psychiatric disorders are prevalent in young adulthood for individuals with a history of JFM, and a current major mood disorder is associated with greater physical impairment. Greater attention to early identification and treatment of mood disorders in patients with JFM is warranted.
AB - Objective. Adolescents with juvenile-onset fibromyalgia (JFM) have increased rates of psychiatric disorders, but to our knowledge no studies have examined psychiatric disorders in adolescents with JFM when they enter young adulthood. This study examined the prevalence of psychiatric disorders in young adults diagnosed with JFM during adolescence and the relationship between mental health diagnoses and physical functioning. Methods. Ninety-one young adults (mean age 21.60, SD 1.96) with a history of JFM being followed as part of a prospective longitudinal study and 30 matched healthy controls (mean age 21.57, SD 1.55) completed a structured interview of psychiatric diagnoses and a self-report measure of physical impairment. Results. Young adults with a history of JFM were more likely to have current and lifetime histories of anxiety disorders (70.3% and 76.9%, respectively) compared with controls (33.3% for both, both p < 0.001). Individuals with JFM were also more likely to have current and lifetime histories of major mood disorders (29.7% and 76.9%, respectively) compared with controls (10% and 40%, p < 0.05). The presence of a current major mood disorder was significantly related to impairment in physical functioning [F (1, 89) = 8.30, p < 0.01] and role limitations attributable to a physical condition [F (1, 89) = 7.09, p < 0.01]. Conclusion. Psychiatric disorders are prevalent in young adulthood for individuals with a history of JFM, and a current major mood disorder is associated with greater physical impairment. Greater attention to early identification and treatment of mood disorders in patients with JFM is warranted.
UR - https://www.scopus.com/pages/publications/84948809053
UR - https://www.scopus.com/pages/publications/84948809053#tab=citedBy
U2 - 10.3899/jrheum.141369
DO - 10.3899/jrheum.141369
M3 - Article
C2 - 26373565
AN - SCOPUS:84948809053
SN - 0315-162X
VL - 42
SP - 2427
EP - 2433
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 12
ER -